26 /100
MEDIUM RISK
Score updated Jul 13, 2026

IART — Integra LifeSciences Holdings Corporation Dilution Risk Tracker

Track IART dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IART — Get alerts when the score changes →

As of July 13, 2026, Integra LifeSciences Holdings Corporation (IART) has a DilutionWatch DilutionScore of 26/100, rated MEDIUM dilution risk. Integra LifeSciences Holdings Corporation has a market capitalization of $1.25B, 77.80M shares outstanding, 204 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
39
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for IART.
🔔 Track IART — Get forecast alerts →

💹 Market Data

Market Cap$1.25B
Shares Outstanding77.80M
Float58.69M
Cash$265.50M
Debt$716.88M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 12.7% shares (2026Q1 vs prior)
204 institutional holders · 88.43M shares
#1 MORGAN STANLEY 11.26M shares
#2 BlackRock, Inc. 10.32M shares
#3 Rubric Capital Management LP 7.75M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest6.39M
Days to Cover5.7
% of Float10.9%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2022
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for IART Shareholders

Integra LifeSciences Holdings Corporation (IART) has a DilutionScore of 26/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for IART shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for IART in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for IART alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track IART Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IART — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for IART
📊 IART FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 IART Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.